V. Schinikerth et al., PYRROLIDINE DITHIOCARBAMATE SELECTIVELY PREVENTS THE EXPRESSION OF THE INDUCIBLE NITRIC-OXIDE SYNTHASE IN THE RAT AORTA, European journal of pharmacology, 265(1-2), 1994, pp. 83-87
Exposure of rat aortic rings without endothelium to interleukin-1 beta
for 5 h significantly attenuated the contractions due to phenylephrin
e and increased the tissue content of guanosine 3',5'-cyclic monophosp
hate (cyclic GMP) due to the induction of nitric oxide synthase. The p
resence of pyrrolidine dithiocarbamate, a specific inhibitor of nuclea
r transcription factor kappa B activation, during the exposure of the
rings to interleukin-1 beta prevented these responses to interleukin-1
beta. Rat aortic rings which had been incubated for 5 h with interleu
kin-1 beta in the absence and presence of pyrrolidine dithiocarbamate
prior to the organ chamber experiment had a similar concentration-depe
ndent relaxation curve for acetylcholine in rings with endothelium, an
d for 3-morpholino-sydnonimine (SIN-1) in rings without. Pyrrolidine d
ithiocarbamate applied acutely did not alter the tone elicited by phen
ylephrine in rings with or without endothelium and had no effect on th
e subsequent relaxation induced by acetylcholine in rings with endothe
lium or by SIN-1 in rings without endothelium. These observations sugg
est that pyrrolidine dithiocarbamate prevents the interleukin-1 beta-m
ediated expression of the inducible nitric oxide synthase without affe
cting the activity of the constitutive enzyme in the rat aorta.